NPC Healthbiz Weekly
Subscribe
Sign in
Home
Podcast
Archive
About
Latest
Top
Discussions
S14 E03 Sobi Canada’s Bob McLay: Life Science Leadership in Rare Disease
Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine.
10 hrs ago
•
Jeremy Visser
1
Share this post
Copy link
Facebook
Email
Notes
More
31:32
Tech-enabled pharmacies are reshaping care. Here’s how to approach the trend
AI-driven telepharmacy, automated workflows, and hybrid ‘tech + touch’ models are cutting processing times and boosting adherence (Issue #336, 1,220…
Jul 15
•
Cristela Tello Ruiz
Share this post
NPC Healthbiz Weekly
Tech-enabled pharmacies are reshaping care. Here’s how to approach the trend
Copy link
Facebook
Email
Notes
More
S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics
Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie…
Jul 10
•
Jeremy Visser
Share this post
Copy link
Facebook
Email
Notes
More
25:00
AI regulation tsunami hits pharma: FDA draft guidance and EU AI Act demand new compliance strategies
As regulatory authorities roll out strict AI oversight frameworks, pharma companies face mounting pressure to embed transparency, validation and bias…
Jul 8
•
Cristela Tello Ruiz
Share this post
NPC Healthbiz Weekly
AI regulation tsunami hits pharma: FDA draft guidance and EU AI Act demand new compliance strategies
Copy link
Facebook
Email
Notes
More
June 2025
mRNA vaccines expand beyond Covid-19 into oncology and infectious diseases
Clinical research surges as mRNA technology shifts toward cancer treatment, rare diseases, and global health threats (Issue #335, 1000 words, 5 minutes)
Jun 24
•
Cristela Tello Ruiz
Share this post
NPC Healthbiz Weekly
mRNA vaccines expand beyond Covid-19 into oncology and infectious diseases
Copy link
Facebook
Email
Notes
More
From faster timelines to smarter clinical trials — How AI is revolutionizing drug discovery
The value lies in enhancing patient recruitment, optimizing study design, and enabling real-time adjustments (Issue #334, 1,300 words, 6.5 minutes)
Jun 17
•
Cristela Tello Ruiz
1
Share this post
NPC Healthbiz Weekly
From faster timelines to smarter clinical trials — How AI is revolutionizing drug discovery
Copy link
Facebook
Email
Notes
More
Tech is transforming the pharma industry, speeding drug discovery and personalizing medicine
It's all about AI, and much more. Get ready for the next waves of disruptive technologies (Issue #333, 1,371 words, 6.5 minutes)
Jun 10
•
Cristela Tello Ruiz
1
Share this post
NPC Healthbiz Weekly
Tech is transforming the pharma industry, speeding drug discovery and personalizing medicine
Copy link
Facebook
Email
Notes
More
Revolutionizing chronic care: The next frontier in precision medicine
From Alzheimer’s breakthroughs to diabetes and cardiovascular innovations, cutting-edge therapies are reshaping treatment paradigms—and the…
Jun 3
•
Cristela Tello Ruiz
Share this post
NPC Healthbiz Weekly
Revolutionizing chronic care: The next frontier in precision medicine
Copy link
Facebook
Email
Notes
More
May 2025
First AbbVie Biotech Innovators Award goes to Neuropeutics
Startup focused on neurodegenerative disease research to receive support from the SpinUp incubator at the University of Toronto Mississauga (Issue #332…
May 27
•
Cristela Tello Ruiz
Share this post
NPC Healthbiz Weekly
First AbbVie Biotech Innovators Award goes to Neuropeutics
Copy link
Facebook
Email
Notes
More
Feds looking for more transparency in drug pricing
Proposed pricing reforms put emphasis on clinical effectiveness and real-world outcomes (Issue #331, 1,200 words, 6 minutes)
May 20
•
Cristela Tello Ruiz
Share this post
NPC Healthbiz Weekly
Feds looking for more transparency in drug pricing
Copy link
Facebook
Email
Notes
More
Pharma regulation 2025: Digital transformation, AI, and global harmonization reshape the compliance landscape
Regulatory agencies worldwide are embracing cloud technologies and AI to streamline approvals, strengthen data integrity, and accelerate innovation…
May 13
•
Cristela Tello Ruiz
Share this post
NPC Healthbiz Weekly
Pharma regulation 2025: Digital transformation, AI, and global harmonization reshape the compliance landscape
Copy link
Facebook
Email
Notes
More
Pharma M&A: What's the global landscape for 2025?
Technological innovation and favourable market conditions drive a new wave of high-stakes mergers and acquisitions in the life sciences (Issue #329…
May 6
•
Cristela Tello Ruiz
Share this post
NPC Healthbiz Weekly
Pharma M&A: What's the global landscape for 2025?
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts